Add Row
Add Element
cropper
update
PractitionersOfHealth - a CapidHouser.com media site
update
Add Element
  • Home
  • Categories
    • dentistry
    • cosmetics
    • opticians
    • physiotherapy
    • chiropractor
    • osteopathy
  • Massage Therapy
  • Yoga Therapy
  • diet and nutrition
  • reflexology
June 21.2025
2 Minutes Read

Eyebrows Raised: Eyelid Surgery Becomes the Most Popular Cosmetic Procedure in 2024

Eyelid surgery preparation showcases a woman's face with surgical markings in 2024.

Revolutionizing Aesthetic Choices: Eyelid Surgery Takes Center Stage

The world of cosmetic surgery is constantly evolving, and in 2024, a surprising trend emerged: eyelid surgery has ascended to the top of the list as the most-performed surgical procedure globally, surpassing the long-favored liposuction. The International Society of Aesthetic Plastic Surgery (ISAPS) revealed this remarkable shift in its annual survey held at the Olympiad World Congress in Singapore.

The stats speak volumes: over 2.1 million eyelid surgeries were conducted, marking a significant 13.4% increase from the previous year. This surge not only highlights the growing interest in facial aesthetics but also reflects a broader societal trend toward prioritizing eye rejuvenation, which is often associated with vitality and youth.

Understanding the Shift: Why Eyelid Surgery?

Many might wonder why eyelid surgery has gained such traction. As we age, our eyelids naturally sag and lose elasticity, which can contribute to a tired or aged appearance. This shift could be attributed to an increased awareness and acceptance of cosmetic procedures, especially as younger adults start to seek preventive solutions for aging.

Interestingly, eyelid surgery has moved beyond gender boundaries. It remains the most popular choice for men, positioned ahead of surgeries like gynecomastia and scar revision. This reflects a cultural shift where men, too, are invested in maintaining a youthful appearance and are embracing aesthetic enhancements.

Exploring the Bigger Picture: Popular Procedures in 2024

Besides eyelid surgery, other cosmetic procedures maintain their popularity, including liposuction and breast augmentation. However, notable changes have emerged in the trends as well. Both liposuction and breast augmentation saw decreases in their overall numbers, potentially signaling a shift in public perception and preferences in aesthetics. Meanwhile, non-surgical treatments such as botulinum toxin and hyaluronic acid fillers remain strong contenders, thanks in part to their less invasive nature.

What This Means for Prospective Patients

For individuals considering cosmetic procedures, the growing inclination towards eyelid surgery offers both insight and opportunity. Not only is it now a leading option, but it also comes with a wealth of experienced surgeons specializing in this area. If you or a family member are looking for a trusted cosmetic surgery expert, there are ample resources available to explore the best eyelid surgery specialists.

Take the Next Step in Your Cosmetic Journey

As the cosmetic surgery landscape continues to evolve, staying informed is key. Explore your options and consult with qualified professionals to ensure you make educated decisions based on current trends and personal aspirations. Whether it’s for yourself or a loved one, now is a great time to consider how aesthetic enhancements can positively impact self-esteem and well-being.

cosmetics

0 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
07.04.2025

FDA Extends Opzelura Review: Hope for Pediatric Atopic Dermatitis Treatment

Update FDA’s Extended Review: Implications for Pediatric Atopic Dermatitis TreatmentThe recent announcement by Incyte regarding the FDA’s extension of the review period for Opzelura, a topical treatment for atopic dermatitis in children aged 2-11, has significant implications for young patients and their families. For many parents, the frustration of watching their child struggle with a chronic skin condition can be overwhelming. This extension, now pushing the Prescription Drug User Fee Act action date to September 19, 2025, means there’s still hope for new treatment avenues amidst increasing numbers of children diagnosed with atopic dermatitis.Understanding Atopic DermatitisAtopic dermatitis is more than just skin deep; it's linked to immune system responses, and managing its symptoms can be challenging. Millions of children in the U.S. deal with this condition, leading to potential sleepless nights and discomfort. Steven Stein, MD, the chief medical officer at Incyte, emphasizes the importance of innovative treatments like ruxolitinib cream, which could offer relief without the steroids typically prescribed for such conditions.Positive Results from Clinical TrialsThe optimism surrounding Opzelura stems from its Phase 3 TRuE-AD3 study, which showcased significant treatment success compared to vehicle (non-medicated) controls. In the study, higher rates of treatment efficacy were recorded, which is essential information for parents seeking effective solutions for their children’s condition. Potential new remedies that minimize reliance on steroids could pave the way for enhanced treatment options.Addressing Safety ConcernsWhen it comes to any new treatment, the safety profile is paramount. Opzelura demonstrated no new safety signals during the trial, and it did not lead to severe adverse events. Learning that the most common side effect—application site pain—was mild and transient offers reassurance to parents exploring treatment options for their young ones.Why Parents Should Stay InformedAs a parent, staying informed about new treatments like Opzelura can be invaluable. Understanding available options, such as which pediatric plastic surgery specialists are trusted for related conditions or how to navigate cosmetic approaches, can empower parents to make informed health decisions for their children. As the FDA continues to evaluate Opzelura's application, the hope is that it will lead to new, safe, and effective treatments for pediatric atopic dermatitis, reducing the hardship many families face daily.

07.04.2025

Opzelura Review Extension: What It Means For Kids with Atopic Dermatitis

Update New Hope for Kids Struggling with Atopic DermatitisThe recent announcement from Incyte regarding their topical treatment, Opzelura, brings a ray of hope for children aged 2 to 11 suffering from atopic dermatitis. This chronic and uncomfortable skin condition affects millions of children in the United States, making effective treatments highly sought after. With the FDA extending the review period to September 19, 2025, more time will be devoted to scrutinizing the chemistry and manufacturing of this promising new drug.Understanding the Importance of OpzeluraCurrent treatments for atopic dermatitis primarily include topical steroids, which can have side effects, especially in young patients. The potential availability of Opzelura as a non-steroidal topical treatment could significantly improve the quality of life for many families. This move towards a less invasive treatment option aligns with broader health trends favoring approaches with fewer complications.What Parents Should Know About Atopic DermatitisAtopic dermatitis can be challenging not only for the child but also for parents who witness their child suffering. Dr. Steven Stein, the Chief Medical Officer at Incyte, emphasizes the vital need for effective non-steroidal treatments. Given Opzelura’s positive results from the TRuE-AD3 study, this cream shows promise, achieving significant treatment success and demonstrating an overall safe profile.Examining the Efficacy of OpzeluraThe Phase 3 study revealed compelling outcomes: children treated with Opzelura had a noticeable improvement in their condition compared to those using a non-medicated cream. In particular, over 75% of patients demonstrated significant improvements in their eczema severity within just eight weeks. Such rapid results can alleviate worry for parents seeking effective solutions.The Future of Pediatric Dermatological TreatmentsThe extended review period also indicates a commitment to ensuring that the drug, once approved, meets the highest standards for safety and efficacy. As families look for trustworthy options for their children’s skin conditions, this could guide parents in their search for the best cosmetic and dermatological care. The anticipation surrounding Opzelura signals a shift in how we might approach not just atopic dermatitis treatment, but also other pediatric skin conditions in the future.As the future unfolds, parents and caregivers are encouraged to stay informed and involved as the FDA navigates its review process. Keeping an eye on upcoming developments can empower families to ask the right questions and pursue the best treatment avenues for their children.

07.04.2025

FDA Delays Decision on Opzelura: What Parents Should Know About Pediatric Atopic Dermatitis

Update The FDA's Deliberation: What It Means for Children's Health The U.S. Food and Drug Administration (FDA) has extended its review period for the supplemental New Drug Application (sNDA) of Opzelura, a topical cream by Incyte intended for treating mild to moderate atopic dermatitis in children aged 2 to 11. This extension, moving the action date to September 19, 2025, allows the FDA crucial time to review additional data concerning the product's manufacturing and controls. Understanding Atopic Dermatitis in Children Atopic dermatitis is a chronic skin condition that affects millions of children across the U.S., often leading to discomfort and distress. Dr. Steven Stein, Incyte’s chief medical officer, emphasizes the necessity for innovative treatment options that do not rely on steroids, which are commonly prescribed but can have side effects. With the global incidence of atopic dermatitis rising, the potential approval of Opzelura could offer an alternative therapeutic strategy for families coping with this condition. Positive Signs from Clinical Trials The green light for Opzelura came after promising results from the phase 3 TRuE-AD3 clinical trial. This study illustrated that significantly more children receiving Opzelura achieved notable improvements in their skin conditions compared to those using a non-medicated control cream. Among the specific measures, 75% demonstrated substantial improvement in the Eczema Area and Severity Index after eight weeks of treatment. The Journey Ahead for Families and Healthcare Providers As families eagerly await FDA's final decision, the extended review period provides a moment of reflection. This protracted timeline urges parents to consider the broader implications of children's health and the importance of reliable, effective treatments that ground themselves in safety and efficacy. As we anticipate the upcoming decision, it also highlights a vital reality: the transformative effect that a new treatment option can have on the lives of children and their families. For parents searching for the best practices to manage their child's health, staying informed about advancements like Opzelura is crucial. If you have a child suffering from atopic dermatitis, consider discussing these developments with your healthcare provider, as they can provide insights tailored to your child’s specific health needs.

Add Row
Add Element
cropper
update
PractitionersOfHealth
cropper
update

Write a small description of your business and the core features and benefits of your products.

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6
Add Element

+447974613172

AVAILABLE FROM 8AM - 5PM

City, State

, ,

Add Element

ABOUT US

Write a small description of your business and the core features and benefits of your products.

Add Element

© 2025 CompanyName All Rights Reserved. Address . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*